TimeScale Financial’s iShares Biotechnology ETF IBB Stock Holding History

TimeScale Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$209K	Hold	1,650	–	–	0.05%	93
2023 Q1	$213K	Sell	1,650 -70	-4%	-$9.16K	0.05%	90
2022 Q4	$201K	Hold	1,720	–	–	0.06%	67
2022 Q3	$201K	Hold	1,720	–	–	0.06%	67
2022 Q2	$202K	Sell	1,720 -191	-10%	-$22.7K	0.06%	67
2022 Q1	$249K	Buy	1,911 +2	+0.1%	+$261	0.06%	65
2021 Q4	$291K	Buy	1,909 +3	+0.2%	+$464	0.07%	59
2021 Q3	$308K	Sell	1,906 -1	-0.1%	-$168	0.07%	52
2021 Q2	$312K	Sell	1,907 -171	-8%	-$26.3K	0.07%	55
2021 Q1	$313K	Buy	2,078 +204	+11%	+$32.4K	0.08%	59
2020 Q4	$284K	Buy	1,874 +182	+11%	+$26K	0.08%	59
2020 Q3	$231K	Buy	1,692 +1	+0.1%	+$136	0.07%	63
2020 Q2	$234K	Buy	1,691 +191	+13%	+$24.3K	0.07%	55
2020 Q1	$161K	Hold	1,500	–	–	0.05%	65
2019 Q4	$180K	Hold	1,500	–	–	0.05%	90
2019 Q3	$149K	Sell	1,500 -150	-9%	-$15.7K	0.05%	97
2019 Q2	$180K	Buy	+1,650	New	+$176K	0.07%	87

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

TimeScale Financial's IBB Position: Q2 2023 in Review

TimeScale Financial held its iShares Biotechnology ETF (IBB) position steady in Q2 2023 at 1,650 shares worth $209K. The position accounts for 0.05% of the portfolio, ranked #93.

TimeScale Financial first reported a position in IBB in Q2 2019 and has held it in 17 quarters since. The position peaked at $313K in Q1 2021. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

TimeScale Financial held 1,650 shares of iShares Biotechnology ETF worth $209K as of Q2 2023.
TimeScale Financial left its iShares Biotechnology ETF share count unchanged in Q2 2023.
iShares Biotechnology ETF made up 0.05% of TimeScale Financial's portfolio in Q2 2023, its #93 holding.
TimeScale Financial first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's iShares Biotechnology ETF position peaked at $313K in Q1 2021.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.